Bernard Kok

Bernard Kok

Company: Poseida Therapeutics

Job title: Senior Scientist


Virtual: Addressing Liver-Targeted Gene Therapy Durability in Pediatric Populations 1:00 pm

Utilising piggyBac integration for stable and durable transgene expression Improving efficiency leading to reduced dosing and lower immunogenicity risk Exploring potential vectors to administer piggyBacRead more

day: Post-Conference Discussion Day - Track A

Exploring Progress of Next Generation Gene Therapy Vectors 1:00 pm - 4:00 pm

Several limitations of current vectors, including immunogenicity concerns and payload size, have the potential to be solved by developing next generation vectors. This workshop will delve into the promise of non-viral vectors, latest viral vector innovations, and overall program implications for progressing novel vectors towards a commercially viable platform. Attend this workshop to learn about:…Read more

day: Workshop G

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.